The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

NCT00242307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

NCT00246922 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

NCT01591044 ·Status: COMPLETED ·Phase: PHASE2

A 12-Week Study in Adult Subjects With Asthma

NCT01516086 ·Status: COMPLETED ·Phase: PHASE2

A Study of RO5036505 in Patients With Moderate to Severe Asthma

NCT00967590 ·Status: WITHDRAWN ·Phase: PHASE2

A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)

NCT03086460 ·Status: COMPLETED ·Phase: PHASE2

Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma

NCT04108377 ·Status: TERMINATED ·Phase: PHASE1

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

NCT00723021 ·Status: COMPLETED ·Phase: PHASE2

GSK2190915 Moderate to Severe Asthma Study

NCT00850642 ·Status: TERMINATED ·Phase: PHASE2

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

NCT01225913 ·Status: RECRUITING ·Phase: PHASE4

Study in Patients With Asthma

NCT00215410 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

NCT01159912 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

NCT01436071 ·Status: COMPLETED ·Phase: PHASE3

A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects

NCT00830427 ·Status: WITHDRAWN ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

NCT01508936 ·Status: COMPLETED ·Phase: PHASE3

A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.

NCT00517816 ·Status: COMPLETED ·Phase: PHASE1

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

NCT00330070 ·Status: COMPLETED ·Phase: PHASE2

12-Week Study in Adult Subjects With Asthma

NCT01516073 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

NCT04187508 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

NCT06376045 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study in Mild Asthmatic Patients

NCT00748306 ·Status: COMPLETED ·Phase: PHASE2

Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol

NCT00940329 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

NCT02301975 ·Status: COMPLETED ·Phase: PHASE3

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

NCT03012061 ·Status: COMPLETED ·Phase: PHASE2

A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

NCT00983658 ·Status: COMPLETED ·Phase: PHASE2